CXCR4 and prostate carcinoma: DHM effectively suppresses the proliferation of prostate cancer cells by reducing angiogenesis and prevents in vitro migration and invasion of PC-3 human prostate cancer cell lines by downregulating the expression of C-X-C motif chemokine receptor 4 (CXCR4) [60].